The Coghlan Group

Bastrop, United States Founded: 2005 • Age: 21 yrs Acquired By Caligorrx
Clinical trial material management and randomization services are offered.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About The Coghlan Group

The Coghlan Group is a company based in Bastrop (United States) founded in 2005 was acquired by Caligorrx in November 2017. The Coghlan Group operates in a competitive market with competitors including Clario, Lightship, SFJ Pharmaceuticals, N-Power Medicine and Cognivia, among others.

  • Headquarter Bastrop, United States
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    Caligorrx

    (Nov 16, 2017)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of The Coghlan Group

Premium access

Detailed funding history for The Coghlan Group

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in The Coghlan Group

The Coghlan Group has secured backing from 1 investor. Prominent investors backing the company include Caligorrx.

All
Investor Description Founded Year Domain Location
Comparator drugs and supplies are sourced for clinical trials.
Locked Locked Locked
Premium access

Investor details for The Coghlan Group

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by The Coghlan Group

Investments
Premium access

Investment portfolio details for The Coghlan Group

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - The Coghlan Group

Premium access

Detailed financials for The Coghlan Group

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

The Coghlan Group Comparisons

The Coghlan Group Primary company
Description
Clinical trial material management and randomization service...
Location
Bastrop, United States
Founded Year
2005
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for The Coghlan Group

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of The Coghlan Group

The Coghlan Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Clario, Lightship, SFJ Pharmaceuticals, N-Power Medicine and Cognivia, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
CRO focused on providing clinical trial supply services for biopharma sector
Locked Locked Locked
Direct-to-patient clinical trial solutions are provided by Lightship.
Locked Locked Locked
Specialty pharmaceutical company based on partnering model
Locked Locked Locked
Clinical trial services are provided to support medical research initiatives.
Locked Locked Locked
Provider of data modeling and patient insights for clinical trial optimization
Locked Locked Locked
Clinical trial imaging workflow and data management technology is provided.
Premium access

Detailed competitors of The Coghlan Group

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on The Coghlan Group

Premium access

Complete news archive for The Coghlan Group

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about The Coghlan Group

The Coghlan Group was founded in 2005.

The Coghlan Group is headquartered in Bastrop, United States. It is registered at Bastrop, Texas, United States.

The Coghlan Group was founded in 2005 in Bastrop, United States, focusing on the clinical trials sector. Services encompass packaging, labeling, and distribution of trial materials, along with storage, inventory management, resupply reporting, return drug accountability, and destruction processes. Medical supplies are also provided, including FDA-approved products for clinical use. Operations support the full lifecycle of trial material handling.

The Coghlan Group's top competitors include Lightship, SFJ Pharmaceuticals and N-Power Medicine.

The Coghlan Group has 1 investor. Key investors include Caligorrx.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available